Hepatocellular Carcinoma—The Influence of Immunoanatomy and the Role of Immunotherapy
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related morbidity and mortality worldwide. Most patients are diagnosed with advanced disease, limiting their options for treatment. While current treatments are adequate for lower staged disease, available systemic treatments are limited, w...
Main Authors: | Keyur Patel, Ryan Lamm, Peter Altshuler, Hien Dang, Ashesh P. Shah |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/18/6757 |
Similar Items
-
Macrophages and hepatocellular carcinoma
by: Zhiqiang Tian, et al.
Published: (2019-09-01) -
Immunotherapy for Hepatocellular Carcinoma: Current Limits and Prospects
by: Cheng Zhong, et al.
Published: (2021-03-01) -
Editorial: Immunotherapy in Hepatocellular Carcinoma
by: Bin Li, et al.
Published: (2021-06-01) -
Blocking siglec-10hi tumor-associated macrophages improves anti-tumor immunity and enhances immunotherapy for hepatocellular carcinoma
by: Nan Xiao, et al.
Published: (2021-06-01) -
The promise of adoptive cellular immunotherapies in hepatocellular carcinoma
by: Peter G. Hendrickson, et al.
Published: (2020-01-01)